GDNF and Parkinson disease: In the 1990s, glial-cell-line-derived neurotrophic factor (GDNF) emerged as a top candidate for treatment of motor impairment in PD based upon encouraging pre-clinical studies in rodent and non-human primates [56,57,58,59].